Datos de EMA - Recogidos por EPG Health - Última actualización 22 July 2016
Indicación/Indicaciones
Tratamiento de los signos y síntomas de la hiperplasia benigna de próstata (HBP) en varones adultos.
Zonas de aprendizaje
Una zona de aprendizaje (ZA) de epgonline.org es un área del sitio reservada a actividades de educación médica autodirigida y detallada sobre una enfermedad, afección o intervención.
Hereditary ATTR amyloidosis
Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.
Centro de conocimientos sobre irrigación
¿Conoce los últimos datos sobre sistemas eficaces de irrigación?
+ 2 more
EADV 2018 Highlights
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.
Atopic Dermatitis
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Anticoagulation Therapy for Stroke Prevention
Anticoagulation therapy for Stroke Prevention Learning Zone offers a deep-dive into atrial fibrillation causes, consequences, diagnosis and management to help you deliver optimal care and prevent strokes in patients living with this common arrhythmia.
Contenido relacionado
No se ha encontrado ningún Ensayos clínicos relacionado
Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management.
Background: Dual inhibition of the mitogen-activated protein kinase pathway with BRAF/MEK inhibitor (BRAFi/MEKi) therapy is a standard treatment for BRAFV600-mutant metastatic melanoma and has...
Añadido hace 3 meses
No se ha encontrado ningún Directrices relacionado
Más información
Categoría | Valor |
---|---|
Designación de medicamento huérfano | No |
Tipo | POM |
Titular de la autorización de comercialización | Recordati Ireland Ltd. |